VESICARE 10 mg Oral Tablet
RxNorm 539815 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for VESICARE 10 mg Oral Tablet (RxCUI 539815). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Astellas Pharma US, Inc. 2
→ Physicians Total Care, Inc. 2

Astellas Pharma US, Inc.

NDC Product
Human Prescription Drug

Vesicare
NDC 51248-150

Generic Name
Solifenacin Succinate
Dosage Form
Tablet, Film Coated
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Vesicare
NDC 51248-151

Generic Name
Solifenacin Succinate
Dosage Form
Tablet, Film Coated
Route
Oral
Marketing
NDA
Active Listing

Physicians Total Care, Inc.

NDC Product

Vesicare
NDC 54868-4705

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
NDA
Excluded / Inactive
NDC Product

Vesicare
NDC 54868-5398

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
NDA
Excluded / Inactive